Examkin

Question

Difficulty: Very hardClinical Preventive Services and Screening

An 18-month-old boy is evaluated at the pediatric clinic for a scheduled health maintenance visit. He was diagnosed with polyarticular juvenile idiopathic arthritis at age 12 months, and his disease is currently well-controlled on a regimen of weekly methotrexate and scheduled infliximab infusions. Due to his initial prolonged illness and hospitalization, he did not receive his routine 12-month or 15-month immunizations. His mother mentions that he currently has mild, clear rhinorrhea and a low-grade temperature of 37.8°C (100.0°F) that started yesterday. She also notes he had a brief episode of audible wheezing during a similar mild cold last month, which completely resolved with supportive care in three days. The mother expresses anxiety about his development; she observes that he can walk up steps with one hand held, scribbles spontaneously with a crayon, and uses 12 distinct single words, but he is not yet combining words into two-word phrases. Vital signs and physical examination today are unremarkable aside from mild nasal congestion. Which of the following is the most appropriate next step in this patient's management?

  1. Perform universal screening for autism spectrum disorderAnswer
  2. B
    Administer the measles, mumps, and rubella vaccine
  3. C
    Refer to a pediatric speech-language pathologist
  4. D
    Prescribe daily maintenance therapy with an inhaled corticosteroid
  5. E
    Prescribe a course of broad-spectrum oral antibiotics

Answer

The correct action is to perform universal screening for autism spectrum disorder.
The correct action is to perform universal screening for autism spectrum disorder. The American Academy of Pediatrics (AAP) Bright Futures guidelines mandate that all toddlers undergo universal screening with a validated autism-specific tool (such as the M-CHAT-R/F) at both the 18-month and 24-month well-child visits. This is a core component of clinical preventive services and must be performed regardless of whether the parents have explicitly raised concerns about social or neurodevelopmental behaviors.

Step-by-Step Solution

1
Analyze the patient's age against standard preventive screening guidelines.
The patient is 18 months old, which is the specific age at which the AAP mandates universal autism spectrum disorder (ASD) screening.
Preventive care milestones dictate specific universal screens regardless of the patient's complex medical history.
2
Evaluate the patient's immunization status and current medications.
Although the patient is overdue for the 12-15 month live vaccines (like MMR and Varicella), they are strictly contraindicated due to his use of infliximab.
Infliximab is a biologic TNF-alpha inhibitor that causes significant immunosuppression, precluding the use of live-attenuated vaccines.
3
Assess the mother's developmental concerns against established milestones.
The patient uses 12 distinct words. Normal language development at 18 months is 10-25 words. Combining words into two-word phrases is a 24-month milestone.
Accurate knowledge of milestones prevents unnecessary specialty referrals for normal development.
4
Determine the appropriate management for the current and historical respiratory symptoms.
The current symptoms represent a common viral cold, and the past wheezing was a typical viral bronchiolitis episode. Neither warrants antibiotics or daily inhaled corticosteroids.
Evidence-based medicine prioritizes antibiotic stewardship and avoids over-medicalization of self-limiting viral illnesses in toddlers.

Key Concept

According to AAP Bright Futures guidelines, universal screening for autism spectrum disorder is required at 18 and 24 months. Furthermore, live vaccines (e.g., MMR) are absolutely contraindicated in patients receiving biologic immunomodulators.
Estimated Time:1m 30s
Rate this question

Topics

Clinical Preventive Services and Screening

More questions from this topic